Skip to main content
. 2017 Feb 26;7(5):1088–1099. doi: 10.7150/thno.18551

Figure 4.

Figure 4

The landscape of major altered genes and potentially druggable pathways in OSCC. Pills show targets of pharmaceuticals (FDA-approved agents or drugs screened in clinical trials). Genes assigned to each pathway are represented with their alteration frequencies (red font, protein-altering mutation; while font, amplification; yellow font, copy loss), and promotive or inhibitory regulations between genes are highlighted.